Inhibition of salmon calcitonin on secretion of progesterone and GnRH-stimulated pituitary luteinizing hormone SHIOW-CHWEN TSAI,1 CHIEN-CHEN LU,1 JIANN-JONG CHEN,1 YU-CHUNG CHIAO,1 SHYI-WU WANG,2 JIUAN-JIUAN HWANG,1 AND PAULUS

Tsai, Shiow-Chwen, Chien-Chen Lu, Jiann-Jong Chen, Yu-Chung Chiao, Shyi-Wu Wang, Jiuan-Jiuan Hwang, and Paulus S. Wang. Inhibition of salmon calcitonin on secretion of progesterone and GnRH-stimulated pituitary luteinizing hormone. Am. J. Physiol. 277 (Endocrinol. Metab. 40): E49–E55, 1999.—The effects of salmon calcitonin (sCT) on the production of progesterone and secretion of luteinizing hormone (LH) were examined in female rats. Diestrous rats were intravenously injected with saline, sCT, human chorionic gonadotropin (hCG), or hCG plus sCT. Ovariectomized (Ovx) rats were injected with saline or sCT. In the in vitro experiments, granulosa cells and anterior pituitary glands (APs) were incubated with the tested drugs. Plasma LH levels of Ovx rats were reduced by sCT injection. Administration of sCT decreased the basal and hCGstimulated progesterone release in vivo and in vitro. 8-BromocAMP dose dependently increased progesterone production but did not alter the inhibitory effect of sCT. H-89 did not potentiate the inhibitory effect of sCT. Higher doses of 25-hydroxycholesterol and pregnenolone stimulated progesterone production and diminished the inhibitory effects of sCT. sCT did not decrease basal release of LH by APs, but pretreatment of sCT decreased gonadotropin-releasing hormone (GnRH)-stimulated LH secretion. These results suggested that sCT inhibits progesterone production in rats by preventing the stimulatory effect of GnRH on LH release in rat APs and acting directly on ovarian granulosa cells to decrease the activities of post-cAMP pathway and steroidogenic enzymes.